BIOMAT Database Logo BIOMAT Database Logo

[Estimation of antioxidative effect of atorvastatin and fluvastatin used in primary prevention of coronary heart disease--effect on lipid peroxidation]. 2005

Jan Kowalski, and Lucjan Pawlicki, and Joanna Grycewicz, and Jan Błaszczyk, and Robert Irzmański, and Tomasz Cegliński, and Edward Kowalczyk, and Beata Liban-Gałka
Katedry Rehabilitacji z Klinika Chorób Wewnetrznych i Rehabilitacji Kardiologicznej, Lodzi.

The study comprised 35 patients with mixed hyperlipidaemia and coronary heart disease (CHD) risk factors (overweight or obesity, low physical activity, family history). Seventeen patients were administered atorvastatin in a dose of 10 mg and 18 -fluvastatin in a dose of 40 mg once daily at bed time for 6 weeks. The control group consisted of 12 clinically healthy subjects with no CHD risk factors. Blood samples for testing were collected from cubital vein of patients after hypolipaemic diet prior to and 6 weeks after drugs application and once in control group. Malondialdehyde (MDA) concentrations in erythrocytes and plasma were determined by the method of Placer et al. MDA concentrations in erythrocytes and plasma were significantly higher (p < 0.05) in patients than in healthy subjects. After 6-week atorvastatin therapy MDA concentrations in erythrocytes and plasma decreased to the values observed in healthy subjects. In fluvastatin group erythrocyte and plasma MDA concentrations were unchanged and still significantly higher in comparison to the healthy subjects. Atorvastatin, contrary to fluvastatin, decreases lipid peroxidation in CHD risk patients.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011322 Primary Prevention Specific practices for the prevention of disease or mental disorders in susceptible individuals or populations. These include HEALTH PROMOTION, including mental health; protective procedures, such as COMMUNICABLE DISEASE CONTROL; and monitoring and regulation of ENVIRONMENTAL POLLUTANTS. Primary prevention is to be distinguished from SECONDARY PREVENTION and TERTIARY PREVENTION. Prevention, Primary,Disease Prevention, Primary,Prevention, Primordial,Primordial Prevention,Disease Preventions, Primary,Preventions, Primordial,Primary Disease Prevention,Primary Disease Preventions,Primordial Preventions
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005229 Fatty Acids, Monounsaturated Fatty acids which are unsaturated in only one position. Monounsaturated Fatty Acid,Acid, Monounsaturated Fatty,Acids, Monounsaturated Fatty,Fatty Acid, Monounsaturated,Monounsaturated Fatty Acids
D005260 Female Females
D006538 Heptanoic Acids 7-carbon saturated monocarboxylic acids. Acids, Heptanoic

Related Publications

Jan Kowalski, and Lucjan Pawlicki, and Joanna Grycewicz, and Jan Błaszczyk, and Robert Irzmański, and Tomasz Cegliński, and Edward Kowalczyk, and Beata Liban-Gałka
[Lipid peroxidation and antioxidative protection in patients with coronary heart disease].
January 2009, Klinicheskaia meditsina,
Jan Kowalski, and Lucjan Pawlicki, and Joanna Grycewicz, and Jan Błaszczyk, and Robert Irzmański, and Tomasz Cegliński, and Edward Kowalczyk, and Beata Liban-Gałka
The role of antioxidative vitamins in primary and secondary prevention of coronary heart disease.
May 1999, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition,
Jan Kowalski, and Lucjan Pawlicki, and Joanna Grycewicz, and Jan Błaszczyk, and Robert Irzmański, and Tomasz Cegliński, and Edward Kowalczyk, and Beata Liban-Gałka
[Antioxidative effect of mammalian liver hydrolyzate on lipid peroxidation].
February 1994, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Jan Kowalski, and Lucjan Pawlicki, and Joanna Grycewicz, and Jan Błaszczyk, and Robert Irzmański, and Tomasz Cegliński, and Edward Kowalczyk, and Beata Liban-Gałka
Antioxidative effect of sesamol and related compounds on lipid peroxidation.
April 1996, Biological & pharmaceutical bulletin,
Jan Kowalski, and Lucjan Pawlicki, and Joanna Grycewicz, and Jan Błaszczyk, and Robert Irzmański, and Tomasz Cegliński, and Edward Kowalczyk, and Beata Liban-Gałka
[Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits].
April 2005, Arquivos brasileiros de cardiologia,
Jan Kowalski, and Lucjan Pawlicki, and Joanna Grycewicz, and Jan Błaszczyk, and Robert Irzmański, and Tomasz Cegliński, and Edward Kowalczyk, and Beata Liban-Gałka
[Atorvastatin: lipid lowering activity, pleiotropic properties and efficacy in prevention of atherosclerosis and coronary heart disease].
January 2004, Kardiologiia,
Jan Kowalski, and Lucjan Pawlicki, and Joanna Grycewicz, and Jan Błaszczyk, and Robert Irzmański, and Tomasz Cegliński, and Edward Kowalczyk, and Beata Liban-Gałka
[Effect of ligustrazine on plasma lipid peroxidation, superoxide dismutase of the coronary heart disease].
January 1994, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine,
Jan Kowalski, and Lucjan Pawlicki, and Joanna Grycewicz, and Jan Błaszczyk, and Robert Irzmański, and Tomasz Cegliński, and Edward Kowalczyk, and Beata Liban-Gałka
[Lipid lowering therapy in primary prevention of coronary heart disease--introduction].
January 1998, Zeitschrift fur Kardiologie,
Jan Kowalski, and Lucjan Pawlicki, and Joanna Grycewicz, and Jan Błaszczyk, and Robert Irzmański, and Tomasz Cegliński, and Edward Kowalczyk, and Beata Liban-Gałka
Cigarette smoking, antioxidants, lipid peroxidation, and coronary heart disease.
May 1993, Annals of the New York Academy of Sciences,
Jan Kowalski, and Lucjan Pawlicki, and Joanna Grycewicz, and Jan Błaszczyk, and Robert Irzmański, and Tomasz Cegliński, and Edward Kowalczyk, and Beata Liban-Gałka
Effect of CETP polymorphism on atorvastatin lipid-regulating effect and clinical prognosis of patients with coronary heart disease.
December 2014, Medical science monitor : international medical journal of experimental and clinical research,
Copied contents to your clipboard!